Optimizing patient access with evidence of product value, effectiveness, and safety from early development through loss of exclusivity.

Learn More
Booth #419, May 19-23

Visit us at ISPOR Baltimore

We are looking forward to connecting with you at the conference. Set up a meeting ahead of time and view our 28 presentations – including short courses, workshops, issue panels, podiums, and posters.

Learn More
finish-line
On-Demand Webinar

Start with the End in Mind: Optimizing Regulatory and Payer Development Strategies

Watch Now
On-Demand Webinar

Patient-Centric Trial Design: Using Patient Engagement and Insights to Improve Clinical Research

Watch Now
speeding car
White Paper

The Drive Toward Pragmatism in Randomized Trials: Are We There Yet?

Read Now
consultation
White Paper

Real-World Studies Need Patients Too! Unique Considerations for Patient Engagement and Retention

Read Now
Statistics Background

Our Work In Action

150+ Drugs/Therapies

supported in the past year

30+ Global Extended Access Programs

in the last 3 years alone with thousands of patients transitioning smoothly from investigational to commercial

130+ Payer Submissions

across 20+ countries in the past 5 years, including reversal of multiple NICE decisions

17 of the 20 Top-Selling Drugs

in 2017 supported in the past 5 years

150+ Peer-Reviewed Publications

and 250+ research posters and presentations per year

Learn More

Latest Publications

Cardiovascular

A Retrospective Study to Assess Resource Utilization and Costs in Patients with Post-Stroke Spasticity in the United Kingdom.

  • Curr Med Res Opin
  • April 2018
Any

Data Extraction for Complex Meta-Analysis (DECiMAL) Guide.

  • Syst Rev.
  • April 2018
Gastroenterology

The Burden of Opioid-Induced Constipation in Younger Patients with Chronic Noncancer Pain.

  • Pain Med
  • April 2018
Read More About Our Publications
What We Do

What We Do

Real-World Evidence

Obtain real-world evidence of value by extracting data from existing sources, collecting primary data, and conducting hybrid studies.

Patient-Centered Research

Develop and evaluate clinical outcomes assessments to support labeling and promotional claims.

Modeling and Meta Research

Empowering healthcare decision making through modeling, meta analyses, literature reviews, and other assessments of information.

Market Access

Optimize market access with cogent payer insights, expert-informed evidence strategy, and persuasive communication of product value.

Interventional Studies

Provide peri- and post-approval evidence via dedicated global operations and custom-tailored study designs.

Pragmatic Studies

Explore patient-centered outcomes and comparative effectiveness using pragmatic studies with adaptive designs.

Medical Writing

Expert medical writing, including medical information, study documentation, and publications, tailored to the peri- and post-approval environment.
ReitsmaDir

In Our Own Words

We are optimizing protocol development and operations in oncology trials, including better anticipation of post-approval needs that can be integrated earlier into trial designs, providing crucial data for activities focused on market access.

Prostate Cancer
CUP Case Study
Case Study

Robust Modeling Helped Convince NICE to Reverse Their Decision

Learn how Evidera’s experts helped to improve access to a mCRPC treatment in a country with traditionally conservative reimbursement for these therapies.

Read More
Case Study

Compassionate Use Program: Rapid Drug Delivery to Patients in Need

Learn how Evidera, as part of PPD, created a global program across 38 countries to provide treatment within 24-48 hours to 3,100 patients.

Read More
Careers

Meaningful Work at Every Level

We assess candidates across a variety of scientific and operational functions. From leaders in their fields, to those who are new to the industry. We employ people who have a proactive mind-set when it comes to the work they do and helping the people they work with.

Learn More
synergy in the office